To observe the effect of two different drugs applied on skin in the elbow, on the veins of the arm.
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and Surgical
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Age above 18 years of any gender
- Individuals where the veins in the cubital fossa
are not visible after application of tourniquet
- BMI between 20 – 30 Kg/m2
Exclusion Criteria
- Refusal to participate
- Any allergy to the study drugs
- Skin lesions over the cubital fossa
- Thrombosed or non-collapsibility of cubital fossa veins identified by USG
- History of deep vein thrombosis or any other vascular disorder
- History of cardiac disease or migraine headaches
- Pregnant or lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the incidence of patients exhibiting visible vein after topical application of study drugs.Timepoint: Every 5 minutes for 30 minutes
- Secondary Outcome Measures
Name Time Method 1. To compare the increase in venous diameter following application of plain lignocaine gel <br/ ><br>with or without topical NTG application, measured with USG. <br/ ><br>2. To observe the onset and duration of vein dilatation. <br/ ><br>3. To observe any changes in the skin at site of application – redness or flushing, temperature <br/ ><br>discrimination. <br/ ><br>4. To observe any change in haemodynamics – BP, HR after topical application of study drugsTimepoint: Every 5 mins for 30 minutes